What they do
VivaLNK manufactures wearable patch sensors and provides a connected cloud platform for remote patient monitoring. Healthcare providers and pharmaceutical researchers use their flexible, continuous ECG patches to track patient cardiac data during clinical trials and post-discharge recovery.
The record
- Vertical
- Cardiovascular
- Sub-segment
- Remote cardiac monitoring
- Product type
- Device
- Stage
- Series B
- Headquarters
- Campbell, USA
- Region
- North America
- Founded
- 2014
- Total funding
- $20M raised
Notable investors: Alumni Ventures Group, Biomedical Funds, Monarch Ventures.